bpc-157 multiple sclerosis clinical trial Ocrelizumab versus Placebo in Primary Progressive Cobalamin Deficiency - MSPCA-Angell CHFUNCT BPC-157:10mg Vial + BAC Water 3ml
bpc-157 multiple sclerosis clinical trialPay in 4 interest-free payments of $6.68 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9